You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 102 Cord-blood derived NK cells, and CAR-T cells, an attractive improved immunotherapy treatment to be considered for hematological malignancies

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
102 Cord-blood derived NK cells, and CAR-T cells, an attractive improved immunotherapy treatment to be considered for hematological malignancies

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020124016
Dec 20201804
Jan 20212001
Feb 20213005
Mar 20213007
Apr 20211602
May 20211208
Jun 20210021
Jul 20210020
Aug 20210036
Sep 20210018
Oct 202126025
Nov 202120016
Dec 2021401
Jan 2022401
Feb 2022601
Mar 2022402
Apr 20223806
May 20223407
Jun 20222200
Jul 20221001
Aug 20221804
Sep 202210206
Oct 20223205
Nov 20221405
Dec 20221400
Jan 20231601
Feb 20233403
Mar 20232400
Apr 20231001
May 20231003
Jun 20231402
Jul 20231405
Aug 20232602
Sep 2023600
Oct 20231004
Nov 20231401
Dec 20233200
Jan 20241800
Feb 2024600
Mar 20241601
Apr 20241000
May 20241001
Jun 20244501
Jul 20241904
Aug 20241401
Sep 20241603
Oct 20241609
Nov 20241203
Dec 20241207
Jan 20251205
Feb 2025406
Mar 2025006
Apr 2025002
May 2025005
Jun 2025003
Total10180297